Qrons Inc.
company.status.inactiveCIK 1689084fmd_1A1JCN2CD5R0M47W9PMT9V92Q3Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Dec 31, 2015 to Dec 31, 2024, 34 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | 0 | 0 | 0 | – | – | – | – | – |
| Research and development | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 0 | 1 | 4 | 2 | 1 | 1 | 1 | 1 | 0 |
| Operating income | (0) | (1) | (4) | (2) | (1) | (1) | (1) | (1) | (0) |
| Non-interest expense | – | – | – | – | – | – | 0 | 0 | – |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | 0 |
| Net income | (0) | (1) | (4) | (2) | (1) | (1) | (1) | (1) | (0) |